Fundraising Fox

Sonder Futures

Venture capital

San Francisco

Also known as Sonder Futures OS

Fox Verdict
Sign up to see your fit

Fund manager profile

Sonder Futures is a venture fund manager based in San Francisco. SEC filings show 4 venture funds on record, most recently Sonder Futures II OS, LP ($8.5M offering) filed August 2024.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
San Francisco, US
Founded
2020
Last 12 months
3 investments
Tracked investments
11

What they invest in

from 10 of 11 portfolio companies

Healthtech ×10Medical Devices ×4Biotech ×3Deep Tech ×1Robotics ×1

HQs:United States×10

Investments · showing 10 of 11

founders shown can be your intro path

By year:2026 · 12025 · 42024 · 12023 · 32021 · 12020 · 111 dated

SS Innovations International, Inc.ssinnovations.cominNASDAQ: SSIIMar 2026SEC filingmedium confidence

SS Innovations International develops surgical robotic systems, including the SSi Mantra platform, for use in robotic surgery such as cardiothoracic procedures.

BiotechHealthtechMedical DevicesRoboticsGurugram, Haryana, US

Sudhir Prem Srivastava(Chairman and Chief Executive Officer)Dr. Sudhir Srivastava(Founder, Chairman & CEO)Milan Rao(Global Chief Operating Officer and Chief Financial Officer)Vishwajyoti P. Srivastava(Chief Executive Officer - Asia Pacific and Director)Barry F. Cohen(Chief Operating Officer - Americas and Director)

BoardTim Adams(Director)

Board seatFrederic H. Moll· per SEC Form D · $18.6M raise · filed Mar 2026

Avail Medsystems, Inc.Oct 2020SEC filinghigh confidence

HealthtechPalo Alto, US

Daniel Hawkins(Executive Officer, Director)F.T. Jay Watkins(Director)

BoardPeter Hebert(Director)

Board seatFrederic MollJay Watkins· per SEC Form D · $100M raise · filed Oct 2020

Co-investorsLux Ventures

BRIUS Technologies, Inc.Apr 2023SEC filinghigh confidence

HealthtechAddison, US

Amir Abolfathi(Director)Lea Ellermeier(Executive Officer, Director)Karen Long(Director)

BoardKate Garrett(Director)inCindy Roark(Director)

Board seatFrederic Moll· per SEC Form D · $11M raise · filed Apr 2023

Co-investorsSonder Capital

Empirical Spine, Inc.Sep 2023SEC filingmedium confidence

HealthtechWoodside, US

Jay Watkins(Director)Francis P. Grillo(Director)Todd Alamin(Director)Don Johnson(Director)Richard Treadwell(Executive Officer, Director)

Board seatJay Watkins· per SEC Form D · $10.3M raise · filed Sep 2023

EndoQuest Robotics, Inc.Aug 2025SEC filingmedium confidence

HealthtechHouston, US

Shane Sevier(Executive Officer)Eduardo Fonseca(Executive Officer, Director)

BoardNeeraj Agrawal(Director)Vipul Patel(Director)

Board seatFrederic Moll· per SEC Form D · $39.7M raise · filed Aug 2025

Insightecinsightec.comin𝕏Jun 2024SEC filingmedium confidence

Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.

HealthtechMedical DevicesTirat Carmel

Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)Eyal Zadicario(General Manager)Menashe Frank(Vice President - Legal)Jun (Jim) Tao(Chief Operating Officer)Maurice R. Ferre(Chairman and Chief Executive Officer)

Board seatFrederic H. Moll· per SEC Form D · $150M raise · filed Jun 2024

Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion Ventures+7 more

Petal Surgicalpetal.healthAug 2025SEC filingmedium confidence

Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.

BiotechDeep TechHealthtechMedical DevicesRedwood City, US

Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)

BoardRony Abovitz(Co-founding Advisor)

Board seatFrederic Moll· per SEC Form D · $17.7M raise · filed Aug 2025

Co-investorsShangBay Capital LLCTSVCDolma Ventures

Reflexionmedicalreflexion.comin𝕏Nov 2023SEC filingmedium confidence

RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.

BiotechHealthtechMedical DevicesHayward, US

Akshay Nanduri(Executive Officer, Director)Samuel Mazin(Executive Officer, Director)

Board seatJay Watkins· per SEC Form D · $201.4M raise · filed Nov 2023

Co-investorsAscension VenturesCatalio Capital Management, LPPfizer Venture InvestmentsSofinnova PartnersSonder CapitalVenrock

uLink Labs, Inc.Dec 2025SEC filingmedium confidence

HealthtechSan Mateo, US

Matthew McLean(Executive Officer)Marcus Weber(Executive Officer, Director)Jayant Charthad(Executive Officer, Director)

BoardAndrew Weiss(Director)in

Board seatJay WatkinsAndy McGibbon· per SEC Form D · $17.6M raise · filed Dec 2025

Co-investorsSonder Capital

VerAvanti Inc.Mar 2025SEC filingmedium confidence

HealthtechBothell, US

Eric Siebel(Executive Officer)Juan Vegarra(Executive Officer)Luis Savastano(Executive Officer)David Goesling(Executive Officer)Russell Garrison(Executive Officer, Director)Gerald McMorrow(Executive Officer, Director)

Board seatFrederic Moll· per SEC Form D · $37.3M raise · filed Mar 2025

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 1

IPOs and acquisitions across the tracked portfolio

SS Innovations International, Inc.NASDAQ: SSII

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is Sonder Futures located?
Sonder Futures is headquartered in San Francisco, US.

Featured in lists